Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AK63
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 181 | 183 | PF00675 | 0.556 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.434 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.630 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.625 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.591 |
CLV_PCSK_FUR_1 | 66 | 70 | PF00082 | 0.576 |
CLV_PCSK_KEX2_1 | 181 | 183 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.627 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.684 |
CLV_PCSK_KEX2_1 | 68 | 70 | PF00082 | 0.704 |
CLV_PCSK_SKI1_1 | 274 | 278 | PF00082 | 0.491 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.593 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.603 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.482 |
DEG_SPOP_SBC_1 | 286 | 290 | PF00917 | 0.646 |
DOC_MAPK_gen_1 | 181 | 187 | PF00069 | 0.545 |
DOC_MAPK_gen_1 | 7 | 15 | PF00069 | 0.550 |
DOC_MAPK_MEF2A_6 | 7 | 15 | PF00069 | 0.545 |
DOC_PP1_RVXF_1 | 165 | 171 | PF00149 | 0.571 |
DOC_USP7_MATH_1 | 158 | 162 | PF00917 | 0.536 |
DOC_USP7_MATH_1 | 231 | 235 | PF00917 | 0.654 |
DOC_USP7_MATH_1 | 286 | 290 | PF00917 | 0.601 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.747 |
DOC_WW_Pin1_4 | 144 | 149 | PF00397 | 0.547 |
DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.550 |
DOC_WW_Pin1_4 | 279 | 284 | PF00397 | 0.549 |
LIG_BRCT_BRCA1_1 | 288 | 292 | PF00533 | 0.619 |
LIG_BRCT_BRCA1_2 | 288 | 294 | PF00533 | 0.614 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.566 |
LIG_FHA_1 | 145 | 151 | PF00498 | 0.403 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.511 |
LIG_FHA_1 | 273 | 279 | PF00498 | 0.513 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.514 |
LIG_FHA_2 | 237 | 243 | PF00498 | 0.625 |
LIG_FHA_2 | 280 | 286 | PF00498 | 0.531 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.580 |
LIG_LIR_Gen_1 | 27 | 37 | PF02991 | 0.625 |
LIG_LIR_Gen_1 | 296 | 305 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.664 |
LIG_LIR_Nem_3 | 296 | 301 | PF02991 | 0.491 |
LIG_SH2_CRK | 30 | 34 | PF00017 | 0.614 |
LIG_SH2_PTP2 | 12 | 15 | PF00017 | 0.577 |
LIG_SH2_SRC | 12 | 15 | PF00017 | 0.577 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.577 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.515 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 257 | 260 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 266 | 269 | PF00017 | 0.431 |
LIG_SH3_3 | 280 | 286 | PF00018 | 0.531 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.548 |
LIG_SUMO_SIM_par_1 | 259 | 267 | PF11976 | 0.462 |
LIG_SUMO_SIM_par_1 | 84 | 90 | PF11976 | 0.544 |
LIG_TRAF2_1 | 210 | 213 | PF00917 | 0.571 |
LIG_TRAF2_1 | 87 | 90 | PF00917 | 0.542 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.435 |
LIG_WRC_WIRS_1 | 115 | 120 | PF05994 | 0.546 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.455 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.561 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.572 |
MOD_CK1_1 | 50 | 56 | PF00069 | 0.769 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.527 |
MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.665 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.492 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.645 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.681 |
MOD_GSK3_1 | 114 | 121 | PF00069 | 0.597 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.540 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.652 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.543 |
MOD_GSK3_1 | 172 | 179 | PF00069 | 0.536 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.607 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.702 |
MOD_N-GLC_1 | 170 | 175 | PF02516 | 0.588 |
MOD_N-GLC_1 | 231 | 236 | PF02516 | 0.673 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.656 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.463 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.556 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.538 |
MOD_PIKK_1 | 186 | 192 | PF00454 | 0.657 |
MOD_PIKK_1 | 251 | 257 | PF00454 | 0.525 |
MOD_PIKK_1 | 95 | 101 | PF00454 | 0.652 |
MOD_PKA_2 | 236 | 242 | PF00069 | 0.566 |
MOD_PKA_2 | 33 | 39 | PF00069 | 0.720 |
MOD_Plk_1 | 162 | 168 | PF00069 | 0.649 |
MOD_Plk_1 | 218 | 224 | PF00069 | 0.507 |
MOD_Plk_2-3 | 256 | 262 | PF00069 | 0.497 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.663 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.529 |
MOD_ProDKin_1 | 144 | 150 | PF00069 | 0.550 |
MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.544 |
MOD_ProDKin_1 | 279 | 285 | PF00069 | 0.548 |
TRG_ENDOCYTIC_2 | 12 | 15 | PF00928 | 0.577 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.714 |
TRG_ER_diArg_1 | 180 | 182 | PF00400 | 0.567 |
TRG_ER_diArg_1 | 208 | 211 | PF00400 | 0.475 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.591 |
TRG_ER_diArg_1 | 32 | 35 | PF00400 | 0.558 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.586 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTL4 | Leptomonas seymouri | 48% | 100% |
A0A0S4JP65 | Bodo saltans | 33% | 100% |
A0A1X0NLR1 | Trypanosomatidae | 46% | 100% |
A0A3R7K5C5 | Trypanosoma rangeli | 46% | 100% |
A0A3S5H5C8 | Leishmania donovani | 95% | 100% |
A4HS77 | Leishmania infantum | 95% | 85% |
C9ZY71 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
O97210 | Leishmania major | 94% | 100% |
V5DEH0 | Trypanosoma cruzi | 44% | 100% |